GLPs, menopause, and what we actually know
Hot flashes, mood, night sweats, weight changes. If a GLP is also in the picture, hormone therapy may change the landscape. The evidence is still early.
A question we get constantly: does hormone therapy change how the body responds to GLP-based medicines? Some early research has reported different weight-change outcomes in postmenopausal women who were also using hormone therapy. That is an interesting signal, and it is exactly the kind of signal that gets rounded up to a rule online.
What is missing is the boring part. The studies are small or observational, the populations are not the same, and the outcomes people care about (energy, sleep, mood, long-term health) are mostly not the outcomes being measured.
Our read: there is a real conversation here, it belongs between a woman and her clinician, and the honest answer today is “we do not know yet.” We will update this note when the evidence moves.
Sources
- Humans, retrospective, observationalWeight loss response to semaglutide in postmenopausal women with and without hormone therapy use (opens in a new tab)Hurtado and colleagues, Menopause, 2024. 16 women on hormone therapy, 90 not
We link to the paper, the trial registry, or the regulator, never to a seller. A study type in the label tells you who or what was actually studied.
Spotted an error or a newer study? Tell the editors. Corrections are noted on the page. Our standards.
Education only. Not medical advice.
Keep reading
More notes
-
QualityA COA can look official. Read it anyway.
HPLC purity is not “99% of this vial is peptide.” It is the relative purity of what was detected, not identity, sterility, or every contaminant.
-
Regulatory
How to read a compounding vote
When a committee votes, the useful post is the named list and the outcome, not a preview that the meeting exists.
Every new note, once a month.
One email a month. The study type named, every time.
Send your request to thepepedit@gmail.com. The editors will add you to the list.